UPDATED May 18, 2024
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CTS | US$52.55 | 1.9% | 18.7% | US$1.6b | US$45.67 | PE30.1x | E21.0% | 0.3% | Tech | ||
APOG | US$66.54 | -0.5% | 71.5% | US$1.5b | US$64.00 | PE14.8x | E3.6% | 1.5% | Capital Goods | ||
AMSF | US$46.37 | -1.1% | -14.7% | US$886.8m | US$56.00 | PE14.4x | E-22.9% | 3.2% | Insurance | ||
ALNT | US$28.81 | -2.7% | -19.5% | US$483.3m | US$39.33 | PE19.6x | E19.7% | 0.4% | Capital Goods | ||
WNC | US$22.47 | -3.5% | -11.6% | US$1.0b | US$27.33 | PE5.1x | E-25.7% | 1.4% | Capital Goods | ||
ORRF | US$26.75 | 0.4% | 55.4% | US$286.8m | US$31.33 | PB1.1x | E55.9% | 3.0% | Banks | ||
QSG | US$2.67 | -22.2% | -65.5% | US$150.8m | US$7.52 | PE5.4x | E43.4% | n/a | Consumer Services | ||
ESQ | US$48.73 | -2.0% | 16.0% | US$380.0m | US$61.00 | PB1.8x | E10.0% | 1.2% | Banks | ||
LYTS | US$15.85 | -0.3% | 21.4% | US$445.6m | US$19.67 | PE16.1x | E11.3% | 1.3% | Capital Goods | ||
TH | US$11.41 | -1.4% | -26.9% | US$1.1b | US$12.00 | PE7.6x | E-44.0% | n/a | Consumer Services | ||
UFPT | US$259.75 | -0.3% | 70.0% | US$2.0b | US$262.50 | PE41.6x | E10.9% | n/a | Healthcare | ||
CBFV | US$22.77 | 1.1% | 22.3% | US$117.1m | US$24.00 | PB0.8x | E-41.3% | 4.4% | Banks | ||
VMD | US$7.11 | -0.5% | -32.9% | US$276.0m | US$12.75 | PE26.7x | E32.2% | n/a | Healthcare | ||
BELF.A | US$74.01 | 3.9% | 66.7% | US$840.6m | US$67.50 | PE12.4x | E-6.8% | 0.3% | Tech | ||
TCBX | US$21.52 | 1.4% | 33.6% | US$293.8m | US$24.75 | PB0.7x | E15.6% | n/a | Banks | ||
PBAM | US$33.93 | -0.8% | 25.7% | US$194.6m | US$48.33 | PB1x | E-12.2% | n/a | Banks | ||
WABC | US$50.37 | 0.7% | 31.6% | US$1.3b | US$56.00 | PB1.7x | E-11.1% | 3.5% | Banks | ||
BCML | US$20.75 | 2.2% | 31.7% | US$231.6m | US$23.67 | PB0.7x | E-7.5% | 1.9% | Banks | ||
CTNM | US$15.50 | -2.0% | n/a | US$389.5m | US$28.00 | PE123.8x | S-76.9% | n/a | Pharmaceuticals & Biotech | ||
TBBK | US$33.69 | 1.8% | 7.8% | US$1.7b | US$47.00 | PB2.1x | E9.9% | n/a | Banks |